[Clinical-experimental study on the characterization of a cardiac glycoside].
作者信息
Hänel J, Meiffert G
出版信息
Med Welt. 1966 Jun 25;26:1404-8.
PMID:5962714
Abstract
摘要
相似文献
1
[Clinical-experimental study on the characterization of a cardiac glycoside].[关于一种强心苷特性的临床实验研究]
Med Welt. 1966 Jun 25;26:1404-8.
2
[Quantitative therapy with cardiac glycosides].[强心苷类药物的定量治疗]
Med Welt. 1966 Aug 27;35:1802-8.
3
[Value of the clinical use of proscillaridin A].[海葱苷A的临床应用价值]
Clin Ter. 1966 Sep 15;38(5):413-24.
4
5
The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.强心苷中糖成分在心房颤动和充血性心力衰竭患者中所起的作用。
J Clin Pharmacol J New Drugs. 1969 May-Jun;9(3):148-54.
6
[Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].[阿克多吉（AY - 22,241）对心功能不全伴慢性心房颤动或扑动患者的作用]
Arch Inst Cardiol Mex. 1974 Jul-Aug;44(4):615-23.
7
[Treatment of cardiac insufficiency with a new cardiac glycoside].[用一种新型强心苷治疗心脏功能不全]
Landarzt. 1965 Jul 10;41(19):831-3.
8
[Therapy of cardiac insufficiency with a new glycoside combination].[一种新型糖苷组合治疗心功能不全]
Dtsch Med J. 1966 Dec 20;17(24):728-30.
9
[Treatment of latent cardiac insufficiency with a new cardiac glycoside].[用一种新型强心苷治疗潜在性心功能不全]
Ther Ggw. 1969 Aug;108(8):1154-6 passim.
10
[The clinical pharmacology of olitoriside].[秋葵苷的临床药理学]
Kardiologiia. 1972 Oct;12(10):70-3.
引用本文的文献
1
Plasma levels after a single oral dose of proscillaridin.单次口服海葱苷后的血浆水平。
Eur J Clin Pharmacol. 1974;7(2):95-7. doi: 10.1007/BF00561321.
2
[Plasma levels, elimination and cumulation of proscillaridin in renal failure (author's transl)].肾衰时海葱苷元的血浆水平、消除与蓄积（作者译）
Klin Wochenschr. 1974 Jul 1;52(13):640-4. doi: 10.1007/BF01468800.
3
Metabolism and excretion of methylproscillaridin by man.甲基海葱苷元在人体中的代谢与排泄
Eur J Clin Pharmacol. 1975 Aug 14;8(6):427-32. doi: 10.1007/BF00562317.
4
On the pharmacokinetics of proscillaridin A in man.海葱苷A在人体中的药代动力学
Eur J Clin Pharmacol. 1975 Aug 14;8(6):421-5. doi: 10.1007/BF00562316.
5
Proscillaridin activity in portal and peripheral venous blood after oral administration to man.人口服后门脉和外周静脉血中的海葱苷活性。
Eur J Clin Pharmacol. 1977 Apr 20;11(4):277-81. doi: 10.1007/BF00607677.
6
Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.甲基海葱苷元在健康人体内的药代动力学和药效学
Eur J Clin Pharmacol. 1976 Jun 15;10(2):101-8. doi: 10.1007/BF00609467.
7
[Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)].海葱次苷-4'-甲醚对冠心病患者左心室压力上升速率的影响（作者译）
Klin Wochenschr. 1977 Jul 15;55(14):705-6. doi: 10.1007/BF01478837.
8
Stability in vitro of methylproscillaridin.甲基海葱苷元的体外稳定性
Eur J Clin Pharmacol. 1977 Apr 20;11(4):267-71. doi: 10.1007/BF00607675.
Zotero 插件